By: Lois Zoppi, BA Reviewed by Kate Anderton, B.Sc (Editor)
Researchers at the University of California, San Diego (UCSD) have uncovered a new genetic variant responsible for blood vessel dysregulation in the development of age-related macular degeneration (AMD), a retinal eye disease whose exact cause is yet to be discovered. The study was published in the journal Stem Cell Reports on 9th May 2019.
What is Age-related Macular Degeneration (AMD)?
Age-related macular degeneration is ranked the third most common cause of blindness after cataracts and glaucoma. The main risk factor for the condition is increasing age, but smoking, high blood pressure, and a family history of the condition can also increase a person’s risk of developing the disease.
Age-related macular degeneration causes the central field of vision to be distorted or lost due to light-sensitive cells in the macula (the part of the eye responsible for providing clear central vision) functionally abnormally when a network of support cells die.
Deposits, also known as drusen, form, and increase in number beneath the retina and cause angiogenesis, the process by which new blood cells are formed. Blood may leak from the new blood cells and cause damage to the retina, which is then less able to convert light into neural signals to trigger visual recognition in the brain.
Discovering a new genetic variant for AMD
Almost 20 different genes have so far been linked to the onset of AMD. In the new study, the researchers found that a genetic variation affecting the expression of the vascular endothelial growth factor (VEGF) gene was also important in AMD onset.
The VEGF gene encodes the VEGF-A protein, which is believed to be the main factor responsible for triggering the growth of blood vessels. Senior author of the study Dr. Kelly A. Frazer, a professor of pediatrics and director of the Institute for Genomic Medicine at UCSD School of Medicine, commented on the gene’s unexpected significance in the condition:
” We didn’t start with the VEGF-A gene when we went looking for genetic causes of AMD, But we were surprised to find that, with samples from just six people, this genetic variation clearly emerged as a causal factor.”
Dr. Kelly A. Frazer
The aim of the study was to further investigate the possible genetic causes that contribute to the heritability of the disease. The researchers worked to “evaluate whether human induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) cells can be used to prioritize and functionally characterize casual variants at age-related macular degeneration (AMD) risk loci.”
Induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to become an embryonic stem cell. To carry out the study, researchers gathered skin samples from six people and converted their skin cells into iPSCs.
Using a mix of specific molecules and growth factors, the researchers were able to reprogram these skin cells into retinal cells. These reprogramed cells possessed similar physiological and molecular characteristics to native retinal cells…….
Source: News Medical life Sciences